How do payers respond to regulatory actions? The case of bevacizumab

Stacie B. Dusetzina, Shellie Ellis, Rachel A. Freedman, Rena M. Conti, Aaron N. Winn, James D. Chambers, G. Caleb Alexander, Haiden A. Huskamp, Nancy L. Keating

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'How do payers respond to regulatory actions? The case of bevacizumab'. Together they form a unique fingerprint.

Social Sciences

Medicine & Life Sciences